Click here to download

Cancer epidemiology: a gender perspective from prevention to end-of-life care
Journal Title: WELFARE E ERGONOMIA 
Author/s: Paolo Giorgi Rossi 
Year:  2018 Issue: Language: Italian 
Pages:  14 Pg. 143-156 FullText PDF:  284 KB
DOI:  10.3280/WE2018-001010
(DOI is like a bar code for intellectual property: to have more infomation:  clicca qui   and here 


The epidemiology of tumors has always been analyzed with an optic of stratification by gender, both because some very relevant sites for incidence and mortality are gender specific, such as breast, uterus, prostate, and because the incidence for some sites is so different between males and females as for example the lung for men, the thyroid for women. This habit of stratification by sex, however, has not fostered a gender perspective in cancer prevention and treatment. In many aspects of prevention and care men and women have different approaches to the disease. The outcomes that the disease has on the state of health have different values, as in the case of the impact of therapies on reproductive health. Finally, there are genuine gender inequalities with a greater impact on economic resources, working conditions and the management of women’s leisure time when it comes to caring for a cancer patient in a family.
Keywords: Gender medicine; epidemiology; cancer; palliative and end-of-life care.

  1. Smith M. (2015). Should HPV vaccination be gender neutral? CMAJ, Aug 11, 187(11): E337-8.
  2. AIOM-AIRTUM (2013). I numeri del cancro in Italia - 2013. -- Testo disponibile al sito: http://www.registri-tumori.it/cms/it/node/4572; ultimo accesso 30 maggio 2017.
  3. Annunziata M.A., Muzzatti B., Narciso D., Mella S., Viel A., Bidoli E .and Dolcetti R. (2011). Mood state profile and coping strategies after BRCA-1/2 genetic test disclosure: a retrospective study in Italy. Support Care Cancer, 19(6): 733-5.
  4. Anttila A. (2007). Cervical cancer screening is effective - the Finnish experience. Entre Nous (WHO Regional Office, Copenhagen), 64: 26-28.
  5. Arbyn M., Anttila A., Jordan J., Ronco G., Schenck U., Segnan N., Wiener H., Herbert A. and von Karsa L., editors (2008). European Guidelines for Quality Assurance in Cervical Cancer Screening. Second edition. Luxembourg: Office for Official Publications of the European Communities.
  6. Audisio R.A., Icardi G., Isidori A.M., Liverani C.A., Lombardi A., Mariani L., Mennini F.S., Mitchell D.A., Peracino A., Pecorelli S., Rezza G., Signorelli C., Rosati G.V. and Zuccotti G.V. (2016). Public health value of universal HPV vaccination. Critical Reviews in Oncology/Hematology, 97: 157-67.
  7. Bruni L., Barrionuevo-Rosas L., Albero G., Aldea M., Serrano B., Valencia S., Brotons M., Mena M., Cosano R., Muñoz J., Bosch F.X., de Sanjose S., et al. (2015). Human papillomavirus and related diseases in Europe. Summary Report 2015-04-08 ([cited 2015 Jul 9]; -- Testo disponibile al sito: http://www.hpvcentre.net/statistics/reports/XEX.pdf .
  8. Campagna di comunicazione Salute - Pari Opportunità contro il tumore alla prostata – 2010. -- Pagina web disponibile all’indirizzo: http://www.salute.gov.it/portale/news/p3_2_6_1_1.jsp?lingua=italiano&menu=campagne&p=dacampagne&id=34; ultimo accesso 30 maggio 2017.
  9. Carreras G., Gallus S., Iannucci L. and Gorini G. (2012). Estimating the probabilities of making a smoking quit attempt in Italy: stall in smoking cessation levels, 1986-2009. BMC Public Health, 12: 183., 10.1186/1471-2458-12-183.DOI: 10.1186/1471-2458-12-183.
  10. Carreras G. and Gorini G. (2013). Time trends of Italian former smokers 1980-2009 and 2010-2030 projections using a Bayesian age period cohort model. International Journal of Environmental Research and Public Health, 11(1): 1-12.
  11. Faggiano F., Versino E. and Lemma P. (2001). Decennial trends of social differentials in smoking habits in Italy. Cancer Causes Control, 12(7): 665-72.
  12. Ferrante G., Minardi V., Possenti V., Quarchioni E., Masocco M., Salmaso S., Braggion M., Campostrini S. and Baldissera S.; Gruppo Tecnico PASSI (2012). Smoke: prevalence is decreasing, but the gap between socioeconomic categories remains. Epidemiologia e Prevenzione, Nov-Dec, 36(6): 371.
  13. Foca F., Mancini S., Bucchi L., Puliti D., Zappa M., Naldoni C., Falcini F., Gambino M.L., Piffer S., Sanoja Gonzalez M.E., Stracci F., Zorzi M. and Paci E.; IMPACT Working Group (2013). Decreasing incidence of late-stage breast cancer after the introduction of organized mammography screening in Italy. Cancer, Jun 1, 119(11): 2022-8.
  14. Forman D., Bray F., Brewster D.H., Gombe Mbalawa C., Kohler B., Piñeros M., Steliarova-Foucher E., Swaminathan R. and Ferlay J., editors (2014). Cancer Incidence in Five Continents, Vol. X, IARC Scientific Publication No. 164. Lyon: International Agency for Research on Cancer.
  15. Gietel-Habets J.J., de Die-Smulders C.E., Derks-Smeets I.A., Tibben A., Tjan-Heijnen V.C., van Golde R., Gomez-Garcia E., Kets C.M. and van Osch L.A. (2017). Awareness and attitude regarding reproductive options of persons carrying a BRCA mutation and their partners. Human Reproduction, Mar 1, 32(3): 588-597.
  16. Giorgi Rossi P., Beccaro M., Miccinesi G., Borgia P., Costantini M., Chini F., Baiocchi D., De Giacomi G., Grimaldi M. and Montella M.; ISDOC Working Group (2007). Dying of cancer in Italy: impact on family and caregiver. The ISDOC survey. Journal of Epidemiology & Community Health, 61: 547-554.
  17. Giorgi Rossi P. and Ronco G. (2013). The present and future of cervical cancer screening programmes in Europe. Current Pharmaceutical Design, 19(8): 1490-1497., 10.2174/138161213804805504DOI: 10.2174/138161213804805504
  18. Giorgi Rossi P., Caroli S., Mancini S., Sassoli De’ Bianchi P., Finarelli A.C., Naldoni C., Bucchi L., and Falcini F., the Emilia-Romagna cervical cancer screening and patology registry group (2015). Screening history of cervical cancers in Emilia-Romagna, Italy: defining priorities to improve cervical cancer screening. European Journal of Cancer Prevention, 24(2): 128-134., 10.1097/CEJ.0000000000000035DOI: 10.1097/CEJ.0000000000000035
  19. Gorini G. (2011). Individual, community, regulatory, and systemic approaches to tobacco control interventions. Epidemiologia e Prevenzione, May-Aug, 35(3-4 Suppl 1): 33-49.
  20. Gorini G., Carreras G., Allara E. and Faggiano F. (2013). Decennial trends of social differences in smoking habits in Italy: a 30-year update. Cancer Causes Control, 24(7): 1385-91. Epub 2013 May.
  21. ITACAN, banca dati dei registri tumori italiani. -- Disponibile sul web all’indirizzo: http://itacan.ispo.toscana.it/italian/itacan.htm; ultimo accesso 30 maggio 2017.
  22. Kwiatkowski K., Coe K., Bailar J.C. and Swanson G.M. (2013). Inclusion of minorities and women in cancer clinical trials, a decade later: Have we improved? Cancer, Aug 15, 119(16): 2956-63.
  23. Lee M.C., Gray J., Han H.S. and Plosker S. (2010). Fertility and reproductive considerations in premenopausal patients with breast cancer. Cancer Control, Jul, 17(3): 162-72.
  24. Ministero della Salute, Direzione Generale della Prevenzione (2005). Raccomandazioni per la pianificazione e l’esecuzione degli screening di popolazione per la prevenzione del cancro della mammella, del cancro della cervice uterina e del cancro del colon retto. Roma: Ministero della Salute. -- Documento disponibile al sito: https://www.osservatorionazionalescreening.it/sites/default/files/allegati/screening_vers_completa.pdf.
  25. Munster P.N. (2013). Fertility preservation and breast cancer: A complex problem. Oncology (Williston Park), Jun, 27(6): 533-9.
  26. NICE (2013). Familial breast cancer: classification, care and managing breast cancer and related risks in people with a family history of breast cancer. Clinical guideline [CG164] Last updated: March 2017. -- Testo disponibile al sito: https://www.nice.org.uk/guidance/cg164; ultimo accesso 30 maggio 2017.
  27. Nygård J.F., Skare G.B. and Thoresen S.Ø. (2002). The cervical cancer screening program-me in Norway, 1992-2000: changes in Pap smear coverage and incidence of cervical cancer. Journal of Medical Screening, 9(2): 86-91.
  28. Osservatorio Nazionale Screening. Piano nazionale della prevenzione 2010-2012. Documento di indirizzo sullo screening per il cancro della prostata. -- Testo disponibile al sito: http://ons.stage-dig.it/sites/default/files/allegati/documentoconsenso_prostata_2dicembre 2010.pdf#overlay-context=it/content/ricerca-e-innovazione; ultimo accesso 30 maggio 2017.
  29. Pagani O., Partridge A., Korde L., Badve S., Bartlett J., Albain K., Gelber R. and Goldhirsch A.; Breast International Group., North American Breast Cancer Group Endocrine Working Group (2011). Pregnancy after breast cancer: if you wish, ma’am. Breast Cancer Research and Treatment, Sep, 129(2): 309-17.
  30. Perry N., Broeders M., de Wolf C., Törnberg R., Holland L. and von Karsa, editors (2006). European guidelines for quality assurance in breast cancer screening and diagnosis. Fourth Edition. Luxembourg: European Communities.
  31. Puliti D., Zappa M., Miccinesi G., Falini P., Crocetti E. and Paci E. (2009). An estimate of overdiagnosis 15 years after the start of mammographic screening in Florence. European Journal of Cancer, Dec, 45(18): 3166-71.
  32. Puliti D., Miccinesi G. and Paci E. (2011). Overdiagnosis in breast cancer: design and methods of estimation in observational studies. Preventive Medicine, Sep, 53(3): 131-3.
  33. Puliti D., Bucchi L., Mancini S., Paci E., Baracco S., Campari C., Canuti D., Cirilli C., Collina N., Conti G.M., Di Felice E., Falcini F., Michiara M., Negri R., Ravaioli A., Sassoli De' Bianchi P., Serafini M., Zorzi M., Caldarella A., Cataliotti L. and Zappa M.; IMPACT COHORT Working Group (2017). Advanced breast cancer rates in the epoch of service screening: The 400,000 women cohort study from Italy. European Journal of Cancer, Apr, 75: 109-116.
  34. Quinn M., Babb P., Jones J. and Allen E. (1999). Effect of screening on incidence of and mortality from cancer of cervix in England: evaluation based on routinely collected statistics. BMJ, Apr 3, 318(7188): 904-8.
  35. Regione Emilia-Romagna (2011). Rischio eredo - familiare per il carcinoma della mammella. -- Testo disponibile al sito: http://bur.regione.emilia-romagna.it/bur/area-bollettini/marzo-periodico-parte-seconda-2a-quindicina-primo-fascicolo-2/rischio-eredo-familiare-per-il-carcinoma-della-mammella-approvazione-linee-guida-per-le-aziende-sanitarie-della-regione-emilia-romagna/allegato-dgr-220-20111; ultimo accesso 30 maggio 2017.
  36. Rowland E. and Metcalfe A. (2014). A systematic review of men’s experiences of their partner’s mastectomy: coping with altered bodies. Psychooncology, Sep, 23(9): 963-74.
  37. Serraino D., Zucchetto A., Gini A., Taborelli M., Ronco G., Giorgi Rossi P., Zappa M., Crocetti E., Franzo A., Falcini F., Visioli C.B., Stracci F., Zorzi M., Federico M., Michiara M., Fusco M., Ferretti S., Pannozzo F., Tisano F. and Zanetti R. (2015). Changes in cervical cancer incidence following the introduction of organized screening in Italy. Preventive Medicine, Jun, 75: 56-63.
  38. Shiloh S., Dagan E., Friedman I., Blank N. and Friedman E. (2013). A follow-up study on men tested for BRCA1/BRCA2 mutations: impacts and coping processes. Psycho-oncology, Feb, 22(2): 417-25.
  39. Swanson G.M. and Bailar J.C. (2002) 3rd. Selection and description of cancer clinical trials participants-science or happenstance? Cancer, Sep 1, 95(5): 950-9.
  40. von Karsa L., Arbyn M., De Vuyst H., Dillner J., Dillner L., Franceschi S., Patnick J., Ronco G., Segnan N., Suonio E., Törnberg S. and Anttila A. (2015). European guidelines for quality assurance in cervical cancer screening. Summary of the supplements on HPV screening and vaccination. Papillomavirus Research, 1: 22-31.
  41. Walsh S.K., Ginsburg E.S., Lehmann L.S. and Partridge A.H. (2017). Oncofertility: Fertile Ground for Conflict Between Patient Autonomy and Medical Values. The Oncologist, Apr 13. -- Testo disponibile al sito: http://theoncologist.alphamedpress.org/content/22/7/860.full.pdf+html.
  42. Willows K., Lennox G. and Covens A. (2016). Fertility-sparing management in cervical cancer: balancing oncologic outcomes with reproductive success. Gynecologic Oncology Research and Practice, Oct 21; 3: 9. eCollection 2016.
  43. Zorzi M., Puliti D., Vettorazzi M., De Lisi V., Falcini F., Federico M., Ferretti S., Moffa I.F., Mangone L., Mano M.P., Naldoni C., Ponti A., Traina A., Tumino R. and Paci E.; IMPACT Working Group (2006). Mastectomy rates are decreasing in the era of service screening: a population-based study in Italy (1997-2001). British Journal of Cancer, Nov 6, 95(9): 1265-8.
  44. Zorzi M., Da Re F., Mantellini P., Naldoni C., Sassoli De’ Bianchi P., Senore C., Turrin A., Visioli C.B. and Zappa M.; Italian colorectal cancer screening survey group. (2015). Screening for colorectal cancer in Italy: 2011-2012 survey. Epidemiologia e Prevenzione, May-Jun, 39(3 Suppl 1): 93-107.

Paolo Giorgi Rossi, Cancer epidemiology: a gender perspective from prevention to end-of-life care in "WELFARE E ERGONOMIA" 1/2018, pp. 143-156, DOI:10.3280/WE2018-001010

   

FrancoAngeli is a member of Publishers International Linking Association a not for profit orgasnization wich runs the CrossRef service, enabing links to and from online scholarly content